LODOTRA cpr ret 2 mg 30 pce

7680604940044 CH-60494 H02AB07 07.10.6.

Reimbursement limitations:

LODOTRA

LODOTRA est utilisé dans le traitement de la polyarthrite rhumatoïde active modérée à sévère chez …

LODOTRA cpr ret 2 mg 30 pce
LODOTRA cpr ret 2 mg 30 pce
LODOTRA cpr ret 2 mg 30 pce
1 / 3
google

Details

Product number
6049402
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
prednisonum 2.00 mg, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium 0.96 mg, calcii hydrogenophosphas dihydricus, glyceroli dibehenas, lactosum monohydricum 41.80 mg, magnesii stearas, povidonum, E 172 (rubrum), E 172 (flavum), pro compresso obducto.

Articles (1)

Lodotra 2 mg, Tabletten mit veränderter Wirkstofffreisetzung
Tabletten mit veränderter Wirkstofffreisetzung
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/07/2021
Patient information leaflet
Français
15/07/2021
Patient information leaflet
Italien
15/07/2021
Professional SmPC
Allemand
15/07/2021
Professional SmPC
Français
15/07/2021
Professional SmPC
Italien
15/07/2021

Detailed composition

Substance Quantity Type Category
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.96 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
41.8 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 36.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2012

Authorization holder

Mundipharma Medical Company,

4052 Basel

Authorization information

Swissmedic authorization number
60494
Drug name
Lodotra, Tabletten mit veränderter Wirkstofffreisetzung
Galenic form
RETT
ATC Code
H02AB07
Authorization status
Z
Dispensation category
B
First authorization
26/08/2011
Authorization expiration date
31/12/9999
IT number
07.10.6.
Domain
Human medicine
Field of application
Ergänzende Behandlung zu DMARDs bei mässiger bis schwerer aktiver rheumatoider Arthritis

Packaging details

Description (FR)
LODOTRA cpr ret 2 mg 30 pce
Description (DE)
LODOTRA Ret Tabl 2 mg 30 Stk
Market launch
26/08/2011
Narcotic (BTM)
No

Other packaging sizes

LODOTRA cpr ret 1 mg 30 pce
30 TABL
View
LODOTRA cpr ret 1 mg 100 pce
100 TABL
View
LODOTRA cpr ret 2 mg 100 pce
100 TABL
View
LODOTRA cpr ret 5 mg 30 pce
30 TABL
View
LODOTRA cpr ret 5 mg 100 pce
100 TABL
View